Citations

Showing 10 of 108083 citations.

Is Continued Perioperative Antithrombotic Therapy Safe When Performing Open Tracheostomy?
Kennedy, Maeve M. , Abdel‐Aty, Yassmeen , Butterfield, Richard , Zhang, Nan , Lott, David G. , Lott, David G

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | January 17, 2023 | Volume: 132 | Issue: 11 | Pages: 1285-1292

10.1177/00034894221147807 | PMID 36647237 Get It

Objectives: To date, there are no specific guidelines on antithrombotic therapy (ATT) management, which includes both anticoagulation and antiplatelet medications, for open tracheostomy. The objective of this study was to evaluate whether the use of perioperative antithrombotic medication during open tracheostomy influences the incidence of perioperative or postoperative complications. Methods: A retrospective review was conducted of all patients who underwent open tracheostomies at a tertiary care medical center from January 2015 to December 2019. Charts were reviewed for demographics, comorbidities, indication for tracheostomy, ATT use, operative details, and complications. Results: A total of 217 tracheostomies were evaluated for this study, of which 148 (68.2%) were not on ATT and 69 (31.8%) were on ATT during surgery. No significant difference was observed based on ATT status in perioperative bleeding ( P = .983), postoperative bleeding ( P = .24), or median days to decannulation ( P = .5986). ATT patients were 2.67 times more likely to experience 30-day mortality than those non-ATT patients ( P = .035). There was only one death due to hemorrhage in the ATT group. This was unrelated to the tracheostomy. This compares to 2 hemorrhage-related deaths in those not on ATT. Conclusion: There was no significant difference in perioperative or postoperative bleeding based on ATT use. Patients on ATT were significantly more likely to experience 30-day mortality, however only one death was due to hemorrhage in the ATT group and was unrelated to tracheostomy. Therefore, continued perioperative ATT use appears to be safe when performing open tracheostomy. Level of Evidence: 4
Erratum: Septic Pulmonary Embolism. A Contemporary Profile
Valerio, Luca , Baddour, Larry M.

Mayo Clinic

Seminars in Thrombosis and Hemostasis | January 16, 2023 | Volume: 49 | Issue: 08 | Pages: e1-e1

10.1055/s-0043-1760843 | PMID 36646110 Get It

Model to predict major complications following liver resection for HCC in patients with metabolic syndrome
Berardi, Giammauro , Ratti, Francesca , Nebbia, Martina , D'Souza, D.M. , Pascual, Franco , Tohme, Samer , D‘Amico, F. , Alessandris, Remo , Simonelli, Ilaria , Basso, Céleste Del , Moro, Amika , Serenari, Matteo , Rotellar, Fernando , Famularo, Simone , Hoffman, Daniel , Onkendi, Edwin, Essaji, Y. , López‐Ben, Santiago , Caula, Cèlia , Rompianesi, Gianluca , Chopra, Asmita , Hilal, Mohammad Abu , Corvera, Carlos U. , Helton, Scott , Troisi, Roberto , Simo, Kerri A. , Conrad, Claudius , Cescon, Matteo , Kwon, Choon Hyuck David , Cherqui, Daniel , Ferrone, Cristina R. , Mazzaferro, Vincenzo , Aldrighetti, Luca , Sposito, Carlo , D'Amico, Francesco E , Alessandris, Remo , Simonelli, Ilaria , Del Basso, Celeste , Fiorentini, Guido , Serenari, Matteo , Rotellar, Fernando , Ivanics, Tommy , Hoffman, Daniel , Lopez Ben, Santiago , Chopra, Asmita , Torzilli, Guido , Cleary, Sean, Ettorre, Giuseppe M , Serrano, Pablo E , Aldrighetti, Luca , Mazzaferro, Vincenzo , Ratti, Francesca , Sposito, Carlo , Dogeas, Epameinondas , Russolillo, Nadia , Fiorentini, Guido , Zimmitti, Giuseppe , Ivanics, Tommy , Sapisochín, Gonzalo , Alseidi, Adnan A. , Cleary, Sean P. , Ferrero, Alessandro , Cillo, Umberto , Geller, David A. , Kingham, T. Peter

Mayo Clinic

Hepatology | January 16, 2023 | Volume: 77 | Issue: 5 | Pages: 1527-1539

10.1097/hep.0000000000000027 | PMID 36646670 Get It

Background: Metabolic syndrome (MS) is rapidly growing as risk factor for HCC. Liver resection for HCC in patients with MS is associated with increased postoperative risks. There are no data on factors associated with postoperative complications. Aims: The aim was to identify risk factors and develop and validate a model for postoperative major morbidity after liver resection for HCC in patients with MS, using a large multicentric Western cohort. Materials and Methods: The univariable logistic regression analysis was applied to select predictive factors for 90 days major morbidity. The model was built on the multivariable regression and presented as a nomogram. Performance was evaluated by internal validation through the bootstrap method. The predictive discrimination was assessed through the concordance index. Results: A total of 1087 patients were gathered from 24 centers between 2001 and 2021. Four hundred and eighty-four patients (45.2%) were obese. Most liver resections were performed using an open approach (59.1%), and 743 (68.3%) underwent minor hepatectomies. Three hundred and seventy-six patients (34.6%) developed postoperative complications, with 13.8% major morbidity and 2.9% mortality rates. Seven hundred and thirteen patients had complete data and were included in the prediction model. The model identified obesity, diabetes, ischemic heart disease, portal hypertension, open approach, major hepatectomy, and changes in the nontumoral parenchyma as risk factors for major morbidity. The model demonstrated an AUC of 72.8% (95% CI: 67.2%–78.2%) (https://childb.shinyapps.io/NomogramMajorMorbidity90days/). Conclusions: Patients undergoing liver resection for HCC and MS are at high risk of postoperative major complications and death. Careful patient selection, considering baseline characteristics, liver function, and type of surgery, is key to achieving optimal outcomes.
Brain bank questionnaire helps in differential diagnosis of parkinsonian disorders: an autopsy study of 150 patients
Martin, Nicholas B. , Koga, Shunsuke , Koga, Shunsuke , Sekiya, Hiroaki , Dickson, Dennis W.

Mayo Clinic

No container title available | January 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2477309/v1 Get It

Abstract Background: As part of the CurePSP brain donation program, a questionnaire was developed to capture basic information from the next-of-kin or someone familiar with the brain donor with respect to symptoms and clinical course. The usefulness of information from the questionnaire has not been assessed. Objective: To assess the value of information from the brain donation questionnaire as it relates to differential diagnosis of parkinsonian disorders. Methods: We reviewed 150 questionnaires, including 50 patients, each with a neuropathologic diagnosis of Lewy body disease (LBD), multiple system atrophy (MSA), or progressive supranuclear palsy (PSP). The frequency of clinical features recorded in the questionnaires was compared for the three disorders, and machine learning algorithm, XGBoost, was applied to tabulated information from the questionnaires to identify features that had predictive value with respect to neuropathologic diagnosis. Results: The information from the questionnaires correlated with core clinical features for each disorder - hallucinations for LBD, autonomic dysfunction for MSA, and early falls for PSP. Age at onset and early falls were identified as the key variables that contributed most to prediction of neuropathology. Conclusion: While less optimal than prospectively collected information, a questionnaire can provide useful clinical information for clinicopathological correlative studies.
Thiamine deficiency disorders in women and children
Keating, Elizabeth M. , Johnson, Casey R. , Nunez, Kristin Cardiel , Fischer, Philip R. , Cardiel Nunez, Kristin E , Fischer, Philip R

Mayo Clinic

Paediatrics and International Child Health | January 16, 2023 | Volume: 43 | Issue: 4 | Pages: 40-49

10.1080/20469047.2023.2167158 | PMID 36645721 Get It

What Are Current Concepts on the Functional Organization of the Locus Coeruleus and Its Role in Cognition and Neurodegeneration?
Benarroch, Eduardo E.

Mayo Clinic

Neurology | January 16, 2023 | Volume: 100 | Issue: 3 | Pages: 132-137

10.1212/wnl.0000000000206736 | PMID 36646470 Get It

Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
Hayun, Hezi, Bhagat, Ashok Kumar, Papo, Niv , Coban, Matt , Radisky, Evette S. , Ozer, Eden , Alfonta, Lital , Caulfield, Thomas R.

Mayo Clinic

No container title available | January 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2446107/v1 | PMID 36712032 Get It

Abstract Matrix metalloproteinases (MMPs) regulate the degradation of extracellular matrix (ECM) components in biological processes. MMP activity is controlled by natural tissue inhibitors of metalloproteinases (TIMPs) that non-selectively inhibit the function of multiple MMPs via interaction with the MMPs' Zn2+-containing catalytic pocket. Recent studies suggest that TIMPs engineered to confer MMP specificity could be exploited for therapeutic purposes, but obtaining specific TIMP-2 inhibitors has proved to be challenging. Here, in an effort to improve MMP specificity, we incorporated the metal-binding non-canonical amino acids (NCAAs), 3,4-dihydroxyphenylalanine (L-DOPA) and (8-hydroxyquinolin-3-yl)alanine (HqAla), into the MMP-inhibitory N-terminal domain of TIMP2 (N-TIMP2) at selected positions that interact with the catalytic Zn2+ ion (S2, S69, A70, L100) or with a structural Ca2+ ion (Y36). Evaluation of the inhibitory potency of the NCAA-containing variants towards MMP-2, MMP-9 and MMP-14 in vitro revealed that most showed a significant loss of inhibitory activity towards MMP-14, but not towards MMP-2 and MMP-9, resulting in increased specificity towards the latter proteases. Substitutions at S69 conferred the best improvement in selectivity for both L-DOPA and HqAla variants. Molecular modeling revealed how MMP-2 and MMP-9 are better able to accommodate the bulky NCAA substituents at the intermolecular interface with N-TIMP2. The models also showed that, rather than coordinating to Zn2+, the NCAA side chains formed stabilizing polar interactions at the intermolecular interface with MMP-2 and MMP-9. The findings illustrate how incorporation of NCAAs can be used to probe and exploit differential tolerance for substitution within closely related protein-protein complexes to achieve improved specificity.
Inflammasome mediated neuronal-microglial crosstalk: a therapeutic substrate of the familial C9orf72 variant of frontotemporal dementia/amyotrophic lateral sclerosis
Trageser, Kyle J. , Yang, Eun‐Jeong , Iban‐Arias, Ruth , Oguchi, Tatsunori, Iqbal, Umar , Wu, Henry, Estill, Molly , Rahim, Md Al, Raval, Urdhva , Herman, Francis , Zhang, Yong Jie , Petrucelli, Leonard , Zhang, Yong‐Jie , Zhang, Yong-Jie , Smith, Chad , Sebastian-Valverde, Maria , Pasinetti, Giulio Maria

Mayo Clinic

No container title available | January 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2420211/v1 Get It

Abstract Intronic G4C2 hexanucleotide repeat expansions (HRE) of C9orf72 are the most common cause of familial variants of frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS). G4C2 HREs in C9orf72 undergo non-canonical repeat-associated translation, producing dipeptide repeat (DPR) proteins, with various deleterious impacts on cellular homeostasis. While five different DPRs are produced, poly(glycine-arginine) (GR) is amongst the most toxic and is the only DPR to accumulate in the associated clinically relevant anatomical locations of the brain. Previous work has demonstrated the profound effects of a poly(GR) model of C9orf72 FTD/ALS, including motor impairment, memory deficits, neurodegeneration, and neuroinflammation. Neuroinflammation is hypothesized to be a driving factor in the disease course; microglia activation is present prior to symptom onset and persists throughout the disease. Here, using an established mouse model of C9orf72 FTD/ALS we investigate the contributions of the nod-like receptor pyrin-containing 3 (NLRP3) inflammasome in the pathogenesis of FTD/ALS. We find that inflammasome-mediated neuroinflammation is increased with microglial activation, cleavage of caspase-1, production of IL-1β and upregulation of Cxcl10 in the brain of C9orf72 FTD/ALS mice. Excitingly, we find that genetic ablation of Nlrp3 significantly improved survival, protected behavioral deficits and prevented neurodegeneration suggesting a novel mechanism involving HRE-mediated induction of innate immunity. The findings provide experimental evidence of the integral role of HRE in inflammasome-mediated innate immunity in the C9orf72 variant of FTD/ALS pathogenesis and suggest the NLRP3 inflammasome as a therapeutic target.
13-Year Analysis of Gender Disparity in Peer Reviewed Burn Literature
Khan, Iman F. , Ketheeswaran, Suvethavarshini, Willey, Brea, Alasgarov, Elvin, Turker, Ismail, Guliyeva, Günel , Hultman, C. Scott, Cooney, Carisa M. , Caffrey, Julie , Cooney, Carisa M , Turker, Ismail

Mayo Clinic

Journal of Burn Care & Research | January 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jbcr/irad003 | PMID 36645329 Get It

Abstract Women are less likely to be senior authors, invited to write in scientific journals, and to be cited in high impact journals. The aim of this study was to investigate trends in authorship and gender differences in peer-reviewed burn literature over 13 years. We performed a retrospective analysis of original research articles published from January 2009 to September 2021 in three burn journals. A gender determination application was used to categorize the gender of the first and senior author. Of the 3,908 articles analyzed, 42.5% had a woman first author and 27.6% had a woman senior author. We identified 2,029 unique senior authors, 29.0% of whom were women. Woman senior authorship was associated with increased odds of woman first authorship [OR=2.31 (95% CI 2.00, 2.67); p<0.001]. The percentage of papers with a woman senior author increased from 17.8% in 2009 to 35.7% in 2021. If this 1.0% (95% CI: 0.50 – 1.51%) linear trend increase per year in woman senior authorship continues, we will expect to see equal proportions of woman and man senior authors in the included journals starting in 2037. The field of burn care is far from reaching gender parity with respect to authorship of peer-reviewed publications. Supporting and encouraging gender concordant and discordant first:last authorship dyads in mentorship as well as redistributing obligations that may detract from authorship opportunities are potential ways to improve parity in authorship and academia.
The interaction of forced expiratory volume in 1 s and N-terminal pro-B-type natriuretic peptide with outcomes after transcatheter aortic valve replacement
Crestanello, Juan A. , Greason, Kevin L. , Mathew, Jessey , Eleid, Mackram F. , Rihal, Charanjit S. , Bagameri, Gabor, Holmes, David R. , Sandhu, Gurpreet S. , Lee, Alexander T., King, Katherine S. , Alkhouli, Mohamad , King, Katherine , Crestanello, Juan A , Nkomo, Vuyisile T. , Rihal, Charanjit S. , Pislaru, Sorin V. , Alkhouli, Mohamad

Mayo Clinic

European Journal of Cardio-Thoracic Surgery | January 16, 2023 | Volume: 63 | Issue: 4 | Pages: No page available

10.1093/ejcts/ezad017 | PMID 36645236 Get It

Abstract OBJECTIVES Low forced expiratory volume in 1 s (FEV1) and elevated N-terminal pro-B-type natriuretic peptide (NT-Pro-BNP) have been individually associated with poor outcomes after transcatheter aortic valve replacement (TAVR). We hypothesized a combination of the 2 would provide prognostic indication after TAVR. METHODS We categorized 871 patients who received TAVR from 2008 to 2018 into 4 groups according to baseline FEV1 (<60% or ≥60% predicted) and NT-Pro-BNP (<1601 or ≥1601 pg/ml): group A (n = 312, high FEV1, low NT-Pro-BNP), group B (n = 275, high FEV1, high NT-Pro-BNP), group C (n = 123 low FEV1, low NT-Pro-BNP) and group D (n = 161, low FEV1, high NT-Pro-BNP). The primary end point was survival at 1 and 5 years. RESULTS Patients in group A had more severe aortic stenosis and achieved the best long-term survival at 1 [93% (95% CI: 90–96)] and 5 [45.3% (95% CI: 35.4–58)] years. Low FEV1 and high NT-Pro-BNP (group D) patients had more severe symptoms, higher Society of Thoracic Surgeons predicted risk of operative mortality, lower ejection fraction and aortic valve gradient at baseline. Patients in group D had the worst survival at 1 [76% (95% CI: 69–83)] and 5 years [13.1% (95% CI: 7–25)], hazard ratio compared to group A: 2.29 (95% CI: 1.6–3.2, P < 0.001) with 25.7% of patients in New York Heart Association class III–IV. Patients in groups B and C had intermediate outcomes. CONCLUSIONS The combination of FEV1 and NT-Pro-BNP stratifies patients into 4 groups with distinct risk profiles and clinical outcomes. Patients with low FEV1 and high NT-Pro-BNP have increased comorbidities, poor functional outcomes and decreased long-term survival after TAVR.